6,7-dimethoxy-4-phenoxyquinazoline | 1180653-47-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6,7-dimethoxy-4-phenoxyquinazoline
• 英文别名: 6,7-Dimethoxy-4-phenoxyquinazoline
• CAS: 1180653-47-7
• 化学式: C₁₆H₁₄N₂O₃
• 分子量: 282.299
• InChiKey: UJKYSUDLADRYMB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  53.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  6,7-dimethoxy-4-phenoxyquinazoline 、 (4-chlorophenylthio)pentafluorobenzene 在 bis[1,2-bis(diphenylphosphino)benzene]hydriderhodium(I) 作用下， 以 氯苯 为溶剂， 反应 3.0h， 以56%的产率得到4-fluoro-6,7-dimethoxyquinazoline
  参考文献：
  名称：

  Rhodium-catalyzed transformation of heteroaryl aryl ethers into heteroaryl fluorides

  摘要：

  一种铑配合物催化了杂芳基芳基醚的C-O键转化为C-F键。

  DOI：

  10.1039/c6cc05400e
• 作为产物：
  描述：

  sodium phenoxide 、 4-氯-6,7-二甲氧基喹唑啉 以 二甲基亚砜 为溶剂， 反应 3.0h， 以100%的产率得到6,7-dimethoxy-4-phenoxyquinazoline
  参考文献：
  名称：

  Preparation of Heteroaryloxetanes and Heteroarylazetidines by Use of a Minisci Reaction

  摘要：

  Introduction of oxetan-3-yl and azetidin-3-yl groups into heteroaromatic bases was achieved by using a radical addition method (Minisci reaction). To demonstrate utility. the process was used to introduce an oxetane Or azetidine into heteroaromatic systems that have found important uses in the drug discovery industry, such as the marketed EGFR inhibitor geftinib, a quinolinecarbonitrile Src tyrosine kinase inhibitor, and the antimalarial hydroquinine.

  DOI：

  10.1021/jo9010624

文献信息

• 1-(3-(6,7-DIMETHOXYQUINAZOLIN-4-YLOXY)PHENYL)-3-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)UREA AS RAF KINASE MODULATOR IN THE TREATMENT OF CANCER DISEASES
  申请人：Ambit Biosciences Corporation

  公开号：EP2947072A1

  公开（公告）日：2015-11-25

  Compounds, compositions and methods are provided for modulating the activity of RAF kinases, including BRAF kinase and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by RAF kinases. The compound is 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea, having the structure or a pharmaceutically acceptable salt, solvate, clathrate or hydrate thereof.

  本发明提供了用于调节 RAF 激酶（包括 BRAF 激酶）活性以及治疗、预防或改善由 RAF 激酶介导的疾病或紊乱的一种或多种症状的化合物、组合物和方法。 该化合物为 1-(3-(6,7-二甲氧基喹唑啉-4-氧基)苯基)-3-(5-(1,1,1-三氟-2-甲基丙-2-基)异恶唑-3-基)脲，其结构为 或其药学上可接受的盐、溶液、凝胶或水合物。
• QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF
  申请人：Ambit Biosciences Corporation

  公开号：EP2268623B1

  公开（公告）日：2015-05-06
• [EN] QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS QUINAZOLINE UTILES EN TANT QUE DE MODULATEURS DES KINASES RAF ET MÉTHODES D'UTILISATION DE CES DERNIERS
  申请人：AMBIT BIOSCIENCES CORPORATON

  公开号：WO2009117080A1

  公开（公告）日：2009-09-24

  Compounds according to formula (I), compositions and methods are provided for modulating the activity of RAF kinases, including BRAF kinase and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by RAF kinases. Formula (I): or a pharmaceutically acceptable salt, solvate, clathrate of hydrate thereof, wherein X is O or S(O)t; Ra is O or S.
• Preparation of Heteroaryloxetanes and Heteroarylazetidines by Use of a Minisci Reaction
  作者：Matthew A. J. Duncton、M. Angels Estiarte、Russell J. Johnson、Matthew Cox、Donogh J. R. O’Mahony、William T. Edwards、Michael G. Kelly

  DOI：10.1021/jo9010624

  日期：2009.8.21

  Introduction of oxetan-3-yl and azetidin-3-yl groups into heteroaromatic bases was achieved by using a radical addition method (Minisci reaction). To demonstrate utility. the process was used to introduce an oxetane Or azetidine into heteroaromatic systems that have found important uses in the drug discovery industry, such as the marketed EGFR inhibitor geftinib, a quinolinecarbonitrile Src tyrosine kinase inhibitor, and the antimalarial hydroquinine.
• Rhodium-catalyzed transformation of heteroaryl aryl ethers into heteroaryl fluorides
  作者：Mieko Arisawa、Saori Tanii、Takeru Tazawa、Masahiko Yamaguchi

  DOI：10.1039/c6cc05400e

  日期：——

  A rhodium complex catalyzed the conversion of the C–O bond of heteroaryl aryl ethers to the C–F bond.

  一种铑配合物催化了杂芳基芳基醚的C-O键转化为C-F键。